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Abstract 
Background: Few population-based studies have assessed the prevalence and the risk factors of non-allergic rhinitis 
(NAR) in comparison to allergic rhinitis (AR). Moreover, epidemiologic data on rhinitis in the elderly subjects and in 
southern Europe are scarce.
Objective: This study aimed at estimating the prevalence and at comparing the risk factor distribution of AR and 
NAR in a general population sample aged 20–84 years in Italy.
Methods: A questionnaire on respiratory symptoms and risk factors was administered to random samples of the 
Italian population aged 20–44 (n = 10,494) 45–64 (n = 2167) and 65–84 (n = 1030) in the frame of the Gene Environ-
ment Interactions in Respiratory Diseases (GEIRD) study. Current AR and NAR were defined according to the self-
reported presence of nasal allergies or of nasal symptoms without a cold or the flu.
Results: NAR showed a significant descending pattern in females from 12.0 % (95 % CI 11.1, 13.1) in the 20–44 year 
age class, to 7.5 % (5.4, 10.3) in the 65–84 year age class (p = 0.0009), and a roughly stable pattern in males, from 
10.2 % (9.3, 11.2) to 11.1 % (8.4, 13.9) (p = 0.5261). AR decreased from 26.6 % (25.7, 27.6) in 20–44 years age class to 
15.6 % (13.3, 18.0) in the 65–84 years age class (p < 0.0001), without gender difference. Subjects living near industrial 
plants and ex- and current smokers had a higher risk of NAR. Current smokers had a lower risk and subjects living in a 
Mediterranean climate a higher risk of AR.
Conclusion: AR and NAR are fairly distinct conditions, as they have a different age, gender and risk factor distribution.
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Background
Rhinitis is an inflammation of the nasal mucosa, which is 
characterized by symptoms such as excessive mucus pro-
duction, congestion, sneezing paroxysm, and nasal pru-
ritus [1]. It is a prevalent chronic disorder that impairs 
the quality of life and is a public cost burden due to 
decreased job performance [2]. Traditionally, rhinitis is 
divided into allergic (AR) and non-allergic (NAR) rhini-
tis. The first one is the most common form, and is associ-
ated with an immunoglobulin E (IgE)-mediated immune 
response against allergens [3]. Also NAR is frequent and 
its symptoms are very similar to those of AR, but the 
affected patients lack of evident IgE-mediated allergy [1]. 
It is an umbrella term for a number of heterogeneous and 
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poorly defined nasal conditions of unknown aetiology 
and pathophysiology [3].
Rhinitis affects about 40 % of western populations and 
studies report that 25–50 % of patients with rhinitis are 
non-allergic [4, 5]. However, data about the prevalence, 
the gender distribution and risk factors of NAR are of 
substantially lesser quantity and quality than what has 
been published with regard to AR [6, 7]. Furthermore, 
to the best of our knowledge, few studies have been con-
ducted on this issue in southern Europe, where climatic 
and environmental conditions may influence the preva-
lence and the risk factors of upper respiratory diseases 
[8].
The present study aimed at investigating the self-
reported prevalence of AR and NAR in the general popu-
lation aged 20–84 years in Italy and to compare the risk 
factor distribution in self-reported allergic and non-aller-
gic rhinitis subjects. For these purposes the data from the 
Gene Environment Interaction in Respiratory Diseases 
(GEIRD) study were used.
Methods
Study design
GEIRD is a two-stage multicentre study [9]. This analy-
sis regards the first stage, in which subjects from the 
general population were cross-sectionally screened for 
respiratory symptoms. Samples of 3000 subjects aged 
20–44 years (male:female = 1:1) were randomly selected 
in each of the seven Italian centres: Ancona, Pavia, 
Salerno, Sassari, Terni, Turin and Verona. Additional 
random samples of about 1000 subjects aged 45–64 and 
65–84  years were selected in four (Pavia, Sassari, Turin 
and Verona) and in two (Sassari and Verona) centres, 
respectively. All the eligible subjects were administered a 
postal questionnaire up to three times in the case of non 
response. A final phone interview was carried out to con-
tact non responders (Table 1).
Ethics, consent and permissions
Ethics approval was obtained in each centre from 
the appropriate ethics committee (Comitato Etico 
dell’Azienda Ospedaliero-Universitaria Ospedali Riu-
niti di Ancona; Comitato di Bioetica della Fondazione 
IRCCS Policlinico San Matteo di Pavia; Comitato Etico 
dell’Azienda Sanitaria Locale SA/2 di Salerno; Comi-
tato di Bioetica dell’Azienda Sanitaria Locale di Sassari; 
Comitato Etico delle Aziende Sanitarie dell’Umbria di 
Perugia; Comitato Etico dell’Azienda Sanitaria Locale 
TO/2 di Torino; Comitato Etico per la Sperimentazione 
dell’Azienda Ospedaliera Istituti Ospitalieri di Verona). 
All participants were fully informed about all aspects 
of the research project and consented to complete and 
return the questionnaire. Those who did not want to 
answer the questionnaire simply did not send back the 
completed questionnaire. Moreover, they could ask for 
their names and addresses to be deleted from the enroll-
ment list, by simply signing an appropriate box on the 
cover letter and returning it without costs.
Screening questionnaire
The GEIRD Screening Questionnaire (available at the 
GEIRD webpage http://www.geird.org) is a modified ver-
sion of the questionnaires used in previous national and 
international studies [10, 11]. Its aim was to investigate 
the presence of respiratory symptoms, asthma, rhinitis, 
chronic bronchitis, dyspnoea and eczema and the expo-
sure to some environmental factors.
Definition of AR and of NAR
The subjects who answered affirmatively to the question 
“Do you have any nasal allergies including hay fever?” 
were classified as subjects with current AR. The sub-
jects who answered affirmatively to the question “Have 
you ever had a problem with sneezing, or a runny or a 
blocked nose when you did not have a cold or the flu?” 
and to the question “Do you still have this nose prob-
lem?” and negatively to the question “Do you have any 
nasal allergies including hay fever?” were classified as 
subjects with current NAR.
Potential determinants of AR and NAR
The following individual-level factors were examined: 
gender, age class [(20–44), (45–64), (65–84)], smok-
ing habits, educational level, residential area, presence 
of industrial plants near home, self-reported intensity 
Table 1 Number (response rate, %) of subjects participat-
ing in  the GEIRD study, according to  centre and  to their 
age-class at enrolment
Ancona, Salerno and Terni did not collect data on subjects in the (45–64) and 
(65–84) year age classes; Turin did not collect data on subjects in the (65–84) 
year age class
a Central or southern Italy
b Northern Italy
Centre Age class (years)
20–44 45–64 65–84
Anconaa 1866 (61.9)
Paviab 966 (37.1) 460 (54.9)
Salernoa 1806 (64.7)
Sassaria 1245 (53.0) 529 (62.8) 439 (44.3)
Ternia 1660 (59.1)
Turinb 1205 (54.6) 502 (60.2)
Veronab 1746 (67.7) 676 (70.1) 591 (60.1)
Total 10,494 (57.2) 2167 (62.3) 1030 (52.2)
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of car and truck traffic near home, self-reported current 
asthma (use of any medicines for asthma or an attack of 
asthma in the last 12  months), self-reported eczema or 
skin allergy confirmed by a doctor. The centre-specific 
percentile rank of cumulative response [12], the type of 
contact (postal waves and telephone interview) and the 
season when the questionnaire was filled in were consid-
ered as potential design confounders.
Moreover, a centre-level variable was considered: geo-
graphical area (northern Italy: Pavia, Turin and Verona; 
central and southern Italy: Ancona, Salerno, Sassari and 
Terni).
Statistical analysis
Multilevel analyses were performed to account for the 
hierarchically clustered structure of the data (subjects 
nested in centres) [13].
Age and gender-adjusted prevalence of AR and of NAR 
were obtained by applying marginal standardization to 
the estimates of multilevel logistic random intercept 
regression models, with level-1 units (subjects) nested 
into level-2 units (centres) and using a dummy indicator 
as the dependent variable (presence/absence of AR, pres-
ence/absence of NAR) and age, gender and design con-
founders as covariates [14].
Approximate percentile 95  % confidence intervals for 
the prevalence estimates were calculated with the ran-
dom intercept model, using a non-parametric bootstrap 
percentile method with a number of replicates equal to 
2000 [15]. The re-sampling scheme used to generate sam-
ples for the simulating study took the hierarchical data 
structure into account. As the level-2 units (centres) in 
the original data were clearly non-random, only level-1 
units (individuals) were resampled, whereas the level-2 
units were taken from the original sample [16].
To identify the factors associated with AR and NAR, 
two additional multilevel logistic random intercept 
regression models were fitted to the data, including all 
the potential determinants. The centre of Ancona was 
excluded from these analyses because the subjects’ infor-
mation on their residential area, industrial plants near 
home and intensity of car traffic near home had not been 
collected. The presence of an interaction between age 
class and gender was assessed by means of the likelihood 
ratio test.
Multivariate associations of potential determinants 
with AR and NAR were expressed by odds ratios (ORs) 
and their 95 % CIs.
The intraclass correlation (ICC) was assessed to meas-
ure the proportion of the variance in the reporting of AR 
and NAR due to centre-level [17].
The statistical analysis was performed using STATA 
software, release 13.0 (Stata Corp, College Station, Tex).
Results
Response rate and main socio‑demographic characteristics 
of subjects
The rate of participation in the screening stage of the sur-
vey ranged from 52.2  % in the age class 65–84  years to 
62.3 % in the age class 45–64 years (Table 1).
The percentage of women was different across age 
groups (p < 0.001). It was 52.3 and 52.2 % in the 20–44 
and 45–64 year age groups, respectively, but lower in the 
65–84 year age group (42.7 %). Smoking habits were sig-
nificantly different in the three age groups (p < 0.001): the 
percentage of current smokers decreased from 27.7 % in 
the 20–44 to 9.6 % in the 65–84 year age class, concomi-
tantly the percentage of ex-smokers increased from 16.2 
to 37.4 %.
Main characteristics of subjects with AR and with NAR
The proportion of subjects reporting sinusitis was signifi-
cantly greater in the subjects with NAR (38.6 %) than in 
the subjects with AR (33.9 %) (p =  0.002). On the con-
trary, the proportion of subjects reporting polyps tended 
to be slightly higher among subjects with AR than among 
subjects with NAR, though this difference was not sig-
nificant (Table 2). The median age at onset of rhinitis was 
significantly lower in subjects with AR (16 years) than in 
subjects with NAR (18 years) (p = 0.001). In addition, the 
proportion of subjects who had used drugs for rhinitis in 
the previous 12  months was significantly greater in the 
subjects with AR (55.8 %) than in the subjects with NAR 
(28.6 %) (p < 0.001).
Table 2 Main characteristics of subjects with AR (n = 3363) and with NAR (n = 1586)
IQR interquartile range: (1st quartile–3rd quartile)
a Information not available for the centres of Ancona, Perugia/Terni and Sassari. The reported percentages refer to 1876 subjects with AR (of them 215 did not report 
whether they had nasal polyposis) and 855 subjects with NAR (of them 34 did not report whether they had nasal polyposis)
AR NAR p value
Median age at onset (years) (IQR) 16 (10–25) 18 (10–30) <0.001
Self-reported sinusitis (%) 33.9 38.6 0.002
Self-reported nasal polyposis (%)a 6.6 5.2 0.177
Use of drugs for rhinitis in the last 12 months (%) 55.8 29.7 <0.001
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Prevalence of AR and of NAR according to age class 
and gender
The crude prevalences by age and gender are reported in 
Table 3.
The adjusted prevalence of AR shows a statistically 
significant and marked descending pattern accord-
ing to age class (Table  4). The adjusted prevalence 
of NAR also decreases with age, but the difference 
among age classes is less evident and the prevalence 
in the 45–64  year age class is similar to that found in 
the 65–84  year age class. When considering the effect 
of gender, there was no difference between males and 
females with regard to the prevalence estimate of 
AR (Fig.  1). On the contrary, the prevalence of NAR 
showed a different trend according to age class in males 
with respect to females (Fig. 1). The prevalence of NAR 
showed a significant descending pattern in females 
from 12.0 % (95 % CI 11.1, 13.1) in the 20–44 year age 
class, to 7.5 % (95 % CI 5.4, 10.3) in the 65–84 year age 
class (p = 0.0009), and a roughly stable pattern in males 
(p = 0.5261), from 10.2 % (95 % CI 9.3, 11.2) to 11.1 % 
(95 % CI 8.4, 13.9).
Determinants of AR and of NAR
After including all the potential determinants, the esti-
mated ICC for the model describing AR was nearly equal 
to 0 (that is <0.0001), indicating that the centre-effect is 
of marginal importance in determining the reporting of 
AR.
Subjects living in northern Italy and current smokers 
were significantly less likely to report AR (Table  5). On 
the contrary, highly educated subjects, subjects with cur-
rent asthma and subjects with eczema showed a higher 
risk of reporting AR. None of the other environmental 
exposures were significantly associated with AR.
After including all the potential determinants, the esti-
mated ICC for the model describing NAR was 0.1281.
Subjects living near industrial plants had a significantly 
higher risk, while subjects living in suburban and in 
rural areas had a significantly lesser risk to report NAR 
(Table  5). Ex- and current smokers had a higher risk of 
reporting NAR than non-smokers. There was no associa-
tion between asthma and NAR and between eczema and 
NAR.
Females were significantly less likely to report AR than 
males and subjects in the older age classes [(45–64), (65–
84) years] were significantly less likely to report AR than 
subjects in the (20–44) year class. (Table 6). As there was 
a significant interaction between gender and age class 
(p =  0.0021), a different pattern of association between 
age class and NAR was estimated in males and females 
(Table  6): females in the (20–44) age class showed a 
higher risk of reporting NAR than females in the older 
age class whereas NAR was similarly frequent in all age 
classes in males [even though males in the (65–84) year 
age class had a non-significant higher risk of reporting 
NAR than males in the (20–44) age class].
Discussion
Our study is one of the few offering a view on the prev-
alence of AR and NAR in people aged 20–84  years. It 
documents that AR and NAR are major health prob-
lems, affecting overall about 39  % of subjects aged 
20–44 years, 30 % of subjects aged 45–64 years and 29 % 
of the elderly.
AR and NAR association with age and gender
Previous studies have found that the prevalence of AR 
peaks around the age of 16–24 and decreases in the sub-
sequent years up to the age of 65–70 [18, 19]. This trend 
was confirmed by the present study, which also demon-
strated that AR became even less prevalent in the 65–85 
age class and that the descending pattern of prevalence 
was similar in men and women. The age related decrease 
in the AR prevalence may be due to the allergen specific 
Table 3 Crude prevalence (%) of  current AR, NAR, and  of 
current rhinitis (either AR or NAR) by age class
Age class (years)
20–44 45–64 65–84
Females
 AR 26.2 21.3 17.8
 NAR 13.6 8.7 9.4
 AR or NAR 38.8 30.0 26.2
Males
 AR 28.6 19.8 17.1
 NAR 11.6 9.9 14.0
 AR or NAR 39.2 29.7 31.1
Total
 AR 27.4 20.6 17.4
 NAR 12.7 9.3 12.0
 AR or NAR 39.1 29.9 29.4
Table 4 Estimated prevalence (%) (bootstrap 95  % CI) 
of  current AR and  NAR by  age class adjusted for  season, 
percentile rank of cumulative response, and type of survey
Age class (years)
20–44 45–64 65–84 p value
AR 26.6 (25.7–27.6) 20.6 (18.8–22.5) 15.6 (13.3–18.0) <0.0001
NAR 11.1 (10.4–11.9) 9.3 (7.9–10.6) 9.5 (7.7–11.5) 0.0418
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IgE level decrease that occurs with aging in atopic indi-
viduals [20]. It has also been proposed that AR is less 
common in subjects over 60 years of age than in younger 
subjects, possibly because the allergic epidemics started 
quite recently [1].
The age and gender related prevalence of NAR was sub-
stantially different from that of AR, since, in men, NAR 
prevalence was roughly stable across age classes, whereas 
it was negatively associated to age in women. The dissim-
ilar pattern seen in women may be related to the reduc-
tion in oestrogen levels with age. Nasal congestion has 
been reported with pregnancy, menses, menarche, and 
the use of oral contraceptives [21].
One interesting finding of the present study was that 
subjects with NAR reported the onset of symptoms at 
older ages compared to subjects with AR. The reason for 
this result is not clear. We are tempted to speculate that 
AR, mainly linked to atopy, appears early in life, whereas 
NAR, which is influenced by the environment, could 
occur later.
Prevalence of AR versus NAR
Data from previous studies suggest that the ratio of AR 
prevalence to NAR prevalence is 3:1 [6, 22, 23]. Our data 
shows that the ratio changed with age: it ranged from 
about 2.4 in young subjects, to 1.6 in subjects who were 
older than 64 years.
It has been suggested that the female gender may be a 
risk factor for the development of NAR [24]. Our results 
confirmed that females have a higher risk of having NAR 
in the population aged between 20 and 44 years, but they 
also showed that the opposite is true when older age 
classes are considered.
Association of AR and NAR with other respiratory diseases
As expected, AR was associated with eczema and 
strongly linked to bronchial asthma [25]. On the con-
trary, we found no relationship between asthma and 
NAR and between eczema and NAR. Our results are in 
line with those reported by Burros et al. who stated that 
asthma almost always has an allergic basis [26]. In con-
trast with our results, Leynart et al. reported an associa-
tion between perennial rhinitis and asthma in nonatopic 
subjects [6]. The reason for this discrepancy is not clear, 
even though the completely different definition of non 
allergic rhinitis may account for the difference.
Self reported sinusitis tended to be more evident in 
subjects with NAR. This finding is in line with what has 
been described by others. In a study on the Danish ado-
lescent and adult population, subjects with NAR were 
found to suffer from recurring headaches and sinusitis 
more frequently with respect to subjects with AR [7]. 
In another study, a mixed sample of Portuguese patients 
with allergic and non allergic rhinitis were studied in a 
Fig. 1 Estimated prevalence (bootstrap 95 % CI) of current AR and NAR by age class and gender, adjusted for season, percentile rank of cumulative 
response, and type of survey
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clinical setting and the authors found that sinusitis was 
more frequent in NAR than in AR subjects [27].
In our study, nasal polyps were more frequently 
reported by subjects with AR than by subjects with NAR. 
However, this difference was not statistically significant, 
and no definite conclusion could be reached.
We did not collect information on the severity of rhi-
nitis in our study. However, the fact that subjects with 
AR used drugs for their nasal problem more frequently 
than subjects with NAR, suggests that nasal symptoms 
are more frequent or severe in AR. On the other hand, it 
is not possible to exclude that subjects with AR, belong-
ing to the higher socio-economic class (as indirectly indi-
cated by a higher level of education), might pay more 
attention to their symptoms in comparison to subjects 
with NAR.
Environmental exposures
Smoking habits
Population studies on the association between tobacco 
smoking and AR have provided inconsistent results, but 
a recent systematic review in adults found that active 
smoking was associated with a decreased risk of AR 
[28]. Our results are in agreement with this finding as we 
found that current smokers were significantly less likely 
to report AR with respect to non-smokers.
There are few population-based studies on the associa-
tion between smoking and NAR, which have consistently 
found an increased risk of having the disease in smokers 
compared to non-smokers [29–31]. Our results are in 
line with these studies.
The apparent protective effect of cigarette smoking on 
AR might be due to the fact that AR is strongly associated 
to asthma (Table  5), and therefore the affected subjects 
tend to avoid the irritant effect of smoking on their air-
ways. As far as the positive association between smoking 
and NAR is concerned, we speculate that nasal mucosa 
may be exposed to a part of the side stream smoke which 
originates from the tip of the cigarette. Moreover, a pro-
portion of smokers exhale smoke through the nose.
Traffic and industrial related air pollution
Several studies have established an association between 
increased air pollution and the increased risk of allergic 
sensitization and the prevalence of rhinitis worldwide 
[29], whereas other studies have failed to detect an asso-
ciation between traffic-related pollution and allergic sen-
sitization or hay fever [30, 31].
We found no significant association of car or truck 
traffic, neither with AR nor with NAR. A self-reported 
assessment of traffic-related air pollution exposures was 
considered in this study, and it is possible that the lack 
of association between traffic frequency and reported 
symptoms is due to bias. However, a previous study car-
ried out in Italy found that self-reported traffic density 
in residential areas was clearly associated with measured 
nitrogen dioxide level [32].
The presence of industrial plants near the residence 
was associated with a higher risk of reporting NAR, but 
not of reporting AR. This finding seems to indicate that 
some environmental exposures may play a role in the 
Table 5 Adjusted ORs (95  % CI) for  the effect of  socio-
demographic and  environmental determinants on  the 
reporting of AR (n = 11,606) and of NAR (n = 11,525)
Adjusted for all the variables included in the table plus gender, age class, centre-
specific percentile rank of cumulative response, type of contact (postal waves 
and telephone interview) and season when the questionnaire was filled in. An 
interaction effect was found between gender and age class on NAR (p = 0.0021), 
and the model for NAR is adjusted for this interaction effect. ORs that are 
significantly different from 1 are reported in italics (p < 0.05)
AR NAR
Smoking habits
 Non smoker 1.00 1.00
 Ex-smoker 0.90 (0.80;1.36) 1.20 (1.02;1.41)
 Current smoker 0.81 (0.72;0.91) 1.43 (1.24;1.66)
Educational level
 Elementary school graduate 1.00 1.00
 Middle school graduate 1.04 (0.80;1.36) 1.17 (0.84;1.63)
 High school 1.34 (1.04;1.73) 1.11 (0.80;1.53)
 College/university 1.49 (1.15;1.95) 1.01 (0.72;1.42)
Geographical area
 Central and Southern Italy 1.00 1.00
 Northern Italy 0.88 (0.80;0.97) 0.55 (0.18;1.70)
Residential area
 City center 1.00 1.00
 Suburban area 0.91 (0.81;1.01) 0.85 (0.74;0.98)
 Rural area 0.91 (0.77;1.08) 0.74 (0.59;0.92)
Presence of industrial plants near home
 No 1.00 1.00
 Yes 1.10 (0.98;1.25) 1.20 (1.02;1.41)
Intensity of car traffic near home
 Occasional/none 1.00 1.00
 Frequent/constant 0.95 (0.83;1.08) 0.96 (0.81;1.13)
Intensity of truck traffic near home
 Occasional/none 1.00 1.00
 Frequent/constant 1.03 (0.92;1.14) 1.10 (0.96;1.28)
Current asthma
 No 1.00 1.00
 Yes 6.85 (5.83;8.05) 1.07 (0.85;1.35)
Doctor-diagnosed eczema
 No 1.00 1.00
 Yes 2.08 (1.84;2.34) 1.05 (0.89;1.25)
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development of non-allergic nasal symptoms and dis-
eases, but not of AR.
Residence in rural areas
Previous studies have found that the prevalence of AR is 
higher in urban than in rural areas [33]. In the current 
study, living in rural areas was negatively, though not sig-
nificantly, associated with AR, but it was negatively and 
significantly associated with NAR. Up until now, little 
is known about how NAR correlates to urban/rural liv-
ing. Nevertheless, our results are consistent with previ-
ous studies that found a trend of increasing prevalence 
of chronic nasal symptoms with increasing degrees of 
urbanization [34, 35].
Northern versus southern Italy
Previous research has shown that climatic factors may 
influence the prevalence of allergic diseases [36–38]. In 
the current study, subjects living in northern Italy were 
found to report AR less frequently than subjects living in 
central and southern Italy, but there was no evidence that 
the geographical area was associated with NAR. To our 
knowledge, no other studies have tried to describe the 
geographical distribution of NAR in Italy.
The risk of having AR was higher in central/southern 
Italy, which has a milder, Mediterranean climate, with 
respect to northern Italy, which has a sub-continental 
climate [39]. These differences in the prevalence of AR 
could be linked to variations in the climate itself or to 
variations in the characteristics and the length of the pol-
len season. On the other hand, other factors related to 
geo-climatic variations, such as different lifestyles, time 
spent outdoors and diet, may contribute to the regional 
differences in the prevalence of AR. The geographical 
variation found in the prevalence of AR, but not of NAR, 
is probably due to factors related to the concentration of 
allergens. Higher temperatures and the coastal climate 
(three of the seven centres that participated in the study 
are central/southern coastal cities) are associated with 
higher levels of allergen exposure [40].
Strengths and limits of the study
The strength of the present study is that it is a large-scale, 
population-based survey, which made it possible to control 
for confounding socio-demographic and environmental 
factors. A possible limitation is that it was only based on a 
screening questionnaire, and we performed no allergy skin 
tests or IgE measurements. Accordingly, the classification 
of rhinitis as AR or NAR was carried out using a subjective 
response. However, this response seems to be very specific 
for AR [19, 41]. In a previous survey conducted in Italy by 
our group, in which the same question we used to iden-
tify subjects with allergic rhinitis (‘Do you have nasal aller-
gies, including hay fever?’) was adopted, it was found that 
atopy was present in most of the subjects reporting allergic 
rhinitis (124/157 = 79 %), whereas it was present only in a 
minority of the remaining subjects [19].
Data on the specificity and sensibility of the definition 
of NAR are lacking. It could be hypothesized that, in view 
of the fact that we had no skin prick test results, some 
of the subjects classified as affected by NAR are in real-
ity atopic and consequently they were incorrectly cat-
egorized. However, if this speculation is true, it is likely 
that the differences in the distribution of the risk factors 
of NAR and AR would be less evident. On the contrary, 
a correct classification could make the differences we 
found even stronger.
Another limitation was the cross-sectional study 
design, which made it difficult to assess if some potential 
risk factors, such as air pollution, are associated with the 
onset of nasal diseases or if they only trigger symptoms of 
an existing illness.
Conclusion
In conclusion, our survey indicates that AR and NAR are 
fairly distinct conditions. Besides having a different age 
and gender distribution, they also have a dissimilar age 
at onset. Of further interest is the fact that the two nasal 
diseases are related to different risk factors. NAR is asso-
ciated with high pollution linked to industrial plants and 
smoking habits. Subjects with a higher education and 
Table 6 Adjusted ORs (95  % CI) for  the effect of  gender 
and  age class on  the reporting of  AR (n = 11,606) and  on 
the reporting of NAR (n = 11,525)
Adjusted for smoking habits, educational level, geographical area, residential 
area, presence of industrial plants near home, intensity of car and truck traffic 
near home, current asthma and doctor-diagnosed eczema, plus centre-specific 
percentile rank of cumulative response, type of contact (postal waves and 
telephone interview) and season when the questionnaire was filled in. ORs that 
are significantly different from 1 are reported in italics (p < 0.05)
For AR, the table shows the main effect of gender and age class separately, 
for NAR, the table shows the ORs that describe the interaction effect between 
gender and age class
AR NAR
Gender
 Male 1.00
 Female 0.83 (0.75;0.91)
Interaction gender ×  
age class: p = 0.0021
Male Female
Age class (years)
 20–44 1.00 1.00 1.22 (1.06;1.70)
 45–64 0.75 (0.65;0.87) 0.95 (0.73;1.23) 0.85 (0.66;1.11)
 65–84 0.53 (0.42;0.68) 1.21 (0.86;1.70) 0.64 (0.40;1.02)
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current smokers had a lower risk of AR, which was more 
frequently reported by subjects living in a Mediterranean 
climate.
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